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doSure® implantation during Jan. 2007-Dec. 2008. Post-operative intrasac
pressure was measured at every office visit. Ratios of sac to systemic pressures
were recorded as mean (MPI) and pulse (PPI) pressure indexes. CT scans
were obtained at every 6 months or anytime an endoleak was suspected.
Aneurysm sac volume was quantitated after constructed by volume render-
ing of CTA.
Results: Technical success of EndoSure implantation was 98%
(175/178). No sensor malfunctioned after successful implantation.
Mean follow-up was 12.5 months (range 1 - 24 months). In EVAR
without endoleak (143/175), sac pressure decreased progressively and
remained plateaued (MPI  0.5, PPI  0.5) for 24 months. There was a
strong correlation (r  0.87) between diminishing sac pressure and
shrinking sac size. Thirty-two endoleaks developed (18.5%). Five type I
endoleaks (3%) were discovered by sac pressure elevation (MPI  0.5)
and pulsatile waveform (PPI  0.5) (Positive Predictive Value 100%).
Twenty-seven type II endoleaks or endotensions (15.5%) were suspected
with variant MPI elevation ( 0.5) but normal PPI ( 0.5)(PPV 100%).
Endoleaks with markedly elevated sac pressure (MPI  1.0) were fol-
lowed by sac volume expansion.
Conclusions: EVAR can be surveillanced safely by sac pressure
monitoring up to 2 years. The type of endoleak can be predicted based on
the character of sac pressure elevation. Suspected endoleak should be
further examined by CTA with sac volume quantitation. Consistent sac
pressure elevation with sac volume expansion warrants aggressive
intervention.
Summary of sac pressure and volume change during
EVAR surveillance
N  175 MPI PPI Sac volume
No endoleak 143  0.5  0.5 Decrease
Type I endoleak 5  0.5  0.5 Same or
increase
Type II endoleak 25  0.5  0.5 Increase if MPI
 1.0
Endotension 2  0.5  0.5 Increase if MPI
 1.0
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Background: The mortality of ruptured abdominal aortic aneurysm
(rAAA) repair is currently 40-50%. Reports indicate that endovascular repair
(EVAR) is feasible for rAAA and may offer potential benefits over open
repair. We examined the NSQIP database to compare 30-day multicentre
outcomes for EVAR vs. open rAAA repair.
Methods: Patients that underwent rAAA repair in the NSQIP database
from 2005 to 2007 were identified through a combination of CPT codes
and ICD-9 diagnoses. Preoperative comorbidities, operative duration and
transfusion, and 30 day outcomes were evaluated using T-tests.
Results: 76.8% of patients underwent open repair as shown:
EVAR Open repair
All
rAAA
Year n % n % n
2005 4 9.3 39 90.7 43
2006 32 24.2 100 75.8 132
2007 63 25.0 189 75.0 252
Total 99 23.2 326 76.8 427EVAR Open repair P
Patient
Characteristics
Age mean years 
S.D.
72.110.5 73.69.3 0.167
Male % 79.8 76.5 0.497
Smoking % 39.4 30.8 0.111
COPD % 19.2 13.4 0.156
Hx. of Angina, MI
or CHF %
9.1 5.8 0.246
Prior Cardiac
Operation or
PCI %
27.3 21.3 0.218
Treated
Hypertension %
64.6 66.8 0.696
Preop. Transfusion
4 u PRBCs %
2.0 6.1 0.108
Preop Albumin
mean g/dL 
S.D.
3.560.78 3.300.73 0.017*
Intraoperative
Variables
Operative time
mean min. 
S.D.
195.0113.4 203.389.5 0.449
Units PRBC
Intraop. mean 
S.D.
4.26.0 11.88.9 0.001*
Postoperative
Outcomes
30 day composite
morbidity (%)
45.5 62.5 0.003*
30 day mortality
(%)
22.2 37.2 0.003*
Wound dehiscence
(%)
0 4.6 0.030*
Ventilator  48
hours (%)
23.2 47.6 0.001*
Sepsis/septic
shock (%)
19.2 29.9 0.037*
Pulmonary adverse
events (%)
34.3 50.0 0.006*
Patient characteristics, intraoperative variables and postoperative outcomes
are summarized in the table above. Groups were comparable in terms of
comorbid conditions, age and gender; requirement for preoperative blood
transfusion indicative of hemodynamic status was similar. Open repair
resulted in much higher requirement for blood transfusion(P0.001) with-
out difference in operating time. Mortality was higher after OR (
P0.003).There was no difference in the rate of cardiac, neurologic or renal
complications but composite morbidity was higher after open repair second-
ary to wound, septic and pulmonary complications.
Conclusions: EVAR appears to offer superior 30 day outcomes after
repair of rAAA. We did not access aneurysm anatomic characteristics to deter-
mine how many patients that had open repair would have been candidates for
EVAR.Theanatomic suitability forEVARhasbeen reported at60% for rAAA.Less
that ¼ of the NSQIP database patients underwent EVAR; preoperative albumin
which is a strong predictor of morbidity and mortality was significantly lower in
patients undergoingopen repair. There has beenno increase in the ratio ofEVAR/
open repair in the last two years. EVAR for rAAA with favorable anatomy could
potentially result in lower mortality andmorbidity as compared to open repair.
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JOURNAL OF VASCULAR SURGERY
Volume 49, Number 5S Rapid Paced Paper Sessions 49SObjectives: To compare the outcomes of surgeon-modified fenestrat-
ed-branched stent grafts (mFBSG) and abdominal debranching (AD) in
patients unfit for conventional open repair of complex abdominal (AAA) and
thoracoabdominal aortic aneurysms (TAAA).
Methods: We reviewed the outcomes of 35 high-risk patients (30
male, 5 female; median age 75 years) treated for large (7.21 cm) complex
AAA and TAAA between 2006 and 2008. Fifteen patients had AD of 43
vessels (26 mesenteric, 17 renal) with aortic stent grafting. Twenty patients
had 1 to 4-vesselmFBSG with branch artery stenting of 52 vessels (32 renal,
18 mesenteric, 2 hypogastric). End-points were mortality, morbidity, pa-
tency, endoleak and re-intervention rates.
Results:mFBSGpatients had higher comorbidity scores (165 vs 123;
P.03) and more (P.05) stress-induced cardiac ischemia (60% vs 27%), renal
insufficiency (65% vs 20%) and trans-renal aneurysm extension (100% vs 67%).
Thenumber of target vessels per patient (2.81)was similar in bothgroups, but
AD patients had more thoracic extension (80% vs 32%; P.05). Technical
success for branch artery stenting was 98% (51/52). mFBSG required more
(P.05) fluoroscopy time (13520min) and contrast dose (10589ml),
but less operative time (15149 min), blood loss (10.8 L) and fluid
requirement (72 L). There was 1 (5%) operative death aftermFBSG and 3
(20%) after AD (P0.19). Patients treated withmFBSG had less complications
(40% vs 73%; P.05), similar paraplegia rate (5% vs 13%; P.39) and decreased
hospital stay (107 days; P.05). Type I endoleak was noted in 3mFBSG (2
resolved) and in 4 AD patients (1 resolved). There was no difference in 1-year
freedom from endoleak (839% vs 749%), re-intervention (839% vs
589%), target vessel patency (959% vs 982%) and survival (728% vs
719%) inmFBSG vs AD patients. Sac shrinkage ( 5mm)was noted in 7 of 9
(78%) mFBSG patients with 6 months follow up, and in none of the AD
patients (P.02). There were nomigrations, component separations, fractures,
or aneurysm ruptures aftermFBSG.
Conclusion: Surgeon-modified fenestrated and branched stent grafts can
be performed with high procedural success in high-risk patients with complex
AAA and TAAA. This study supports the use ofmFBSG as an alternative to AD
in patients who are suitable candidates for both techniques.
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Background: Growth of small abdominal aortic aneurysms (AAAs) is
frequently associated with aortic neck and iliac artery (IA) changes during
surveillance. The purpose of this study was to determine the effects of aortic
neck and IA changes on anatomic suitability for endovascular aortic aneu-
rysm repair (EVAR ) during long-term follow-up, particularly of small AAAs
with marginal neck morphology (length 15 mm and diameter28 mm).
Methods: We studied 62 patients with small AAAs (diameter, 4 cm to
5.4 cm) under surveillance with long-term follow-up by CT angiography
and 3D reconstructions. The mean follow-up duration was 36 months
(interquartile range [IQR], 16-53 months). AAA morphology and changes
were measured according to SVS reporting standards. Suitability for EVAR
was determined by neck anatomy (diameter, length and angulations, throm-
bosis), IA morphology and all AAA angulations.
Results: Themedian age of the study cohort was 74 years (IQR, 65-77
years). Marginal necks were present in 22 (35%) small AAAs on initial CTA.
Of these AAAs with marginal necks, 74% were considered suitable for
EVAR. Themedian AAA diameter increased from 44.5mm (IQR, 41-48) to
51.1 mm (IQR, 46-55). The aortic neck diameter increased from 23.0 mm
to 25.9 mm (P.001), whereas neck length decreased from 26.5 mm to
19.0 mm (P.001). No significant changes in aortic and IA morphology/
angulation occurred. Overall, the anatomic suitability for endovascular
repair significantly changed during the study period (81% vs 69%; McNemar
test, P.001). Of note, 45% of AAAs with marginal neck morphology vs. 3%
of those with adequate necks were not suitable for EVAR at the end of
follow-up (P.001). In fact, AAAs with marginal necks had a 17-fold
increased risk of losing anatomic suitability for EVAR during surveillance
(odds ratio, 16.8; 95% confidence interval, 4.0-69).
Conclusions: Significant changes in aortic neck morphology and EVAR
suitability occur during long-term surveillance of small AAAs. EVAR suitability
is primarily affected in small AAAs with marginal neck morphology. Our data
indicate that early elective EVAR for small AAAs withmarginal necks is justified
when this is the preferred treatment option, as ongoing surveillance in such
patients may result in aortic neck changes that preclude future EVAR.Author Disclosures: C.H. Timaran, None; F.J. Veith, None; A.E. Mar-tinez, None; E.B. Rosero, None; J. Modrall, None; R. Valentine, None;
G. Clagett, None.
RR13.
Outside the IFU: Do Results Justify Aggressive EVAR Deployment in
Short Angled Aortic Necks?
Jason T Lee, Monica M Dua, Mediget Teshome, Marcin Maruszewski, E.
John Harris, Jr., Cornelius Olcott, IV, Christopher K Zarins, Ronald L
Dalman. Stanford University Medical Center, Stanford, CA
Objective: Widespread community adoption of EVAR has led to
changing referral patterns to academic centers, now consisting of more
patients with unsuitable anatomy defined in the instructions for use (IFU) of
endografts. Treatment of AAAs with high-risk anatomy (neck
length15mm, neck angle 60o) using commercially available devices has
become more common with increasing institutional experience. We exam-
ined whether placement of approved devices in short angled necks provides
acceptable durability at early and intermediate time points.
Methods: 218 patients (197 men, 21 women) underwent elective
EVAR at a single academic center from 2004-2007 with at least 1 year
follow-up. All available pre- and post-op imaging and clinical follow-up were
reviewed. Patients were divided into suitable anatomy (IFU) and high-risk
(non-IFU) categories.
Results: IFU (n143) patients underwent repair with Excluder (40%),
AneuRx (34%), and Zenith (26%) devices, while non-IFU (n75) were
treated primarily with Zenith (57%). Demographics between the groups
were similar, and anatomic details are in Table 1. Operative mortality was
1.4% and morbidity was 11.9%, with mean follow-up of 24 months (range
1-60). Non-IFU patients tended to have larger sac diameters, shorter,
conical, and more angled necks, and were more likely to require suprarenal
fixation, placement of proximal cuffs, and increased fluoroscopy time. There
were no early or late surgical conversions. Rates of migration, endoleak, need
for 2nd procedures, sac regression, and freedom from aneurysm-related
death were similar between the groups.
Conclusions: EVAR can be performed safely in high-risk patients with
unfavorable neck anatomy using commercially-available endografts. Supra-
renal fixation and proximal cuffs are often required for optimal results.
Mid-term outcomes are comparable to those achieved in patients with
suitable anatomy using the same devices. Long-term follow-up will continue
to be necessary to confirm the benefit of treating these high-risk patients.
Preoperative AAA
measurements
Total
(n218)
IFU
(n143)
Non-
IFU
(n75) P-value
AAA max diameter (mm) 58.5 56.9 61.5 .002
Neck length (mm) 24 25 13 .0001
% Neck length  10mm 10.6% 0% 30.7% .0001
% Conical necks 33.5% 25.2% 49.3% .0001
Neck angulation (deg) 30 15 59 .0001
% Neck angle 60 deg 23.8% 0.7% 68% .0001
Associated iliac aneurysm 24.8% 25.9% 22.7% NS
Procedural
characteristics
% Suprarenal fixation use 37.2% 26.6% 57.3% .0001
% Proximal cuff use 6.0% 2.1% 13.3% .003
Estimated blood loss
(mL)
357 347 377 NS
Fluoroscopy time (min) 27.1 24.7 31.3 .02
Contrast use (mL) 118 118 119 NS
Mid-term Outcomes
% Migration10mm 2.3% 2.1% 2.7% NS
% Type I endoleak 5.5% 5.6% 5.3% NS
% Type II endoleak 37.6% 41.3% 30.7% NS
% 2nd procedure 16.5% 17.5% 14.7% NS
Mean sac regression
(mm)
5.1 4.9 5.5 NS
Kaplan-Meier Estimates
Freedom from aneurysm-
related death
2-year
3-year
97.1%
97.1%
98.5%
98.5%
NS
NS
Overall survival 2-year 84.8% 88.2% NS
3-year 81.6 % 77.9% NS
Author Disclosures: J.T. Lee, None; M.M. Dua, None; M. Teshome,
None; M. Maruszewski, None; E. Harris, None; C. Olcott, None; C.K.
Zarins, Medtronic AVE; R.L. Dalman, None.
